Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ratner

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Pediatrics|June 6, 2022
Childhood Violence Exposure Predicts High Blood Pressure in Black American Young AdultsGaurav Kapur, Anaïs F Stenson, Lisa M Chiodo, et al.
Allergy|November 18, 2003
Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment periodJ van Adelsberg, G Philip, A J Pedinoff, et al.
Clinical Therapeutics|November 1, 1996
The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effectsW C Howland, F C Hampel, B G Martin, et al.
Allergy and Asthma Proceedings|April 9, 1998
The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitisH B Kaiser, S R Findlay, J W Georgitis, et al.
Current Medical Research and Opinion|July 19, 2006
Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspectiveCharles E Lamb, Paul H Ratner, Clarion E Johnson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitisCharles P Andrews, Paul H Ratner, Benjamin R Ehler, et al.
The Journal of Urology|June 1, 1985
Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infectionsG J Domingue, J A Roberts, R Laucirica, et al.
Allergy and Asthma Proceedings|May 8, 2007
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescentsBruce G Martin, Paul H Ratner, Frank C Hampel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 9, 2002
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the springG Philip, K Malmstrom, F C Hampel, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Pediatrics|June 6, 2022
Childhood Violence Exposure Predicts High Blood Pressure in Black American Young AdultsGaurav Kapur, Anaïs F Stenson, Lisa M Chiodo, et al.
Allergy|November 18, 2003
Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment periodJ van Adelsberg, G Philip, A J Pedinoff, et al.
Clinical Therapeutics|November 1, 1996
The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effectsW C Howland, F C Hampel, B G Martin, et al.
Allergy and Asthma Proceedings|April 9, 1998
The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitisH B Kaiser, S R Findlay, J W Georgitis, et al.
Current Medical Research and Opinion|July 19, 2006
Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspectiveCharles E Lamb, Paul H Ratner, Clarion E Johnson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitisPaul H Ratner, Mark A Wingertzahn, Julius H van Bavel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitisCharles P Andrews, Paul H Ratner, Benjamin R Ehler, et al.
The Journal of Urology|June 1, 1985
Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infectionsG J Domingue, J A Roberts, R Laucirica, et al.
Allergy and Asthma Proceedings|May 8, 2007
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescentsBruce G Martin, Paul H Ratner, Frank C Hampel, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 9, 2002
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the springG Philip, K Malmstrom, F C Hampel, et al.
Pageof 14